Jazz Pharmaceuticals Financial Overview
Jazz Pharmaceuticals's market cap is currently $10.31B. The company's EPS TTM is $8.13; its P/E ratio is -27.17; Jazz Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $6.38. See an overview of income statement, balance sheet, and cash flow financials.
